46 companies

Limbach Holdings

Market Cap: US$976.8m

Operates as a building systems solution company in the United States.

New

LMB

US$84.01

7D

-2.3%

1Y

-14.0%

Harmony Biosciences Holdings

Market Cap: US$2.1b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

HRMY

US$36.41

7D

-1.2%

1Y

-6.1%

Global Industrial

Market Cap: US$1.3b

Through its subsidiaries, operates as an industrial distributor of various industrial and maintenance, repair, and operation (MRO) products in the United States and Canada.

GIC

US$32.20

7D

5.3%

1Y

33.8%

Applied Industrial Technologies

Market Cap: US$10.8b

Distributes industrial motion, power, control, and automation technology solutions in the United States, Canada, Mexico, Australia, New Zealand, Singapore, and Costa Rica.

AIT

US$287.03

7D

10.6%

1Y

7.2%

Pegasystems

Market Cap: US$6.7b

Develops, markets, licenses, hosts, and supports enterprise software in the United States, rest of the Americas, the United Kingdom, rest of Europe, the Middle East, Africa, and the Asia-Pacific.

PEGA

US$38.20

7D

-14.4%

1Y

-27.4%

Vita Coco Company

Market Cap: US$3.2b

Develops, markets, and distributes coconut water products under the Vita Coco brand name in the United States, Canada, Europe, the Middle East, Africa, and the Asia Pacific.

COCO

US$56.99

7D

6.8%

1Y

51.8%

Pinterest

Market Cap: US$13.4b

Operates as a visual search and discovery platform in the United States, Canada, Europe, and internationally.

PINS

US$19.32

7D

-13.6%

1Y

-42.5%

ResMed

Market Cap: US$38.3b

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.

RMD

US$267.05

7D

3.7%

1Y

12.6%

Stride

Market Cap: US$3.6b

Provides proprietary and third-party online curriculum, software systems, and educational services in the United States and internationally.

LRN

US$86.43

7D

2.8%

1Y

-37.9%

ACADIA Pharmaceuticals

Market Cap: US$4.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$23.46

7D

-8.7%

1Y

22.6%

Page 2 of 2